CEO Of A Biotech Company Fighting The FLU, Covid-19, & Other Viral Diseases

Jim Martin, Co-CEO and CFO of Cocrystal Pharma $COCP


Website: www.cocrystalpharma.com





About Jim:


Mr. James Martin has over 25 years of finance and management
experience including providing financial leadership to
commercial-stage, publicly traded health science companies.





Prior to Cocrystal, Mr. Martin served as the Chief Financial
Officer of Motus GI (Nasdaq: MOTS), a medical device company.
From September 2014 to November 2016 he served as the Chief
Financial Officer of VBI Vaccines, Inc. (formerly SciVac
Therapeutics, Inc.) (Nasdaq: VBIV), a pharmaceutical development
and manufacturing company. From April 2014 to September 2015, Mr.
Martin served as Chief Financial Officer of Vapor Corp, Inc.
(Nasdaq: VPCO), a vaporizer retail and wholesale company. From
January 2011 to October 2013.





Mr. Martin served as Chief Financial Officer of SafeStitch prior
to its merger with TransEnterix, Inc. (NYSE: TRXC). Mr. Martin
also serves as the Chief Financial Officer of Non-Invasive
Monitoring Systems, Inc. (OTC Pink: NIMU), a company marketing
non-invasive medical devices. Mr. Martin holds an undergraduate
degree in business administration and an MBA from Barry
University in Miami. He is a Certified Public Accountant.